RI
REGN icon

Redwood Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Redwood Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,724
Closed -$4.19M – 200
2015
Q4 		$4.19M Buy
7,724
+669
+9% +$362K 0.45% 50
2015
Q3 		$3.28M Buy
7,055
+988
+16% +$531K 0.44% 49
2015
Q2 		$3.1M Buy
6,067
+55
+0.9% +$26.8K 0.38% 60
2015
Q1 		$2.71M Sell
6,012
-5,176
-46% -$2.19M 0.44% 56
2014
Q4 		$4.59M Sell
11,188
-3,419
-23% -$1.34M 0.69% 51
2014
Q3 		$5.27M Sell
14,607
-197
-1% -$66K 0.7% 48
2014
Q2 		$4.18M Sell
14,804
-11,228
-43% -$3.33M 0.52% 60
2014
Q1 		$7.82M Buy
26,032
+1,375
+6% +$424K 1.13% 37
2013
Q4 		$6.79M Buy
24,657
+8,526
+53% +$2.45M 1.02% 39
2013
Q3 		$5.05M Sell
16,131
-113
-0.7% -$29.7K 0.72% 57
2013
Q2 		$3.65M Buy
+16,244
New +$3.78M 0.56% 62

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redwood Investments's REGN Position: Q1 2016 in Review

Redwood Investments sold out of Regeneron Pharmaceuticals (REGN) in Q1 2016, closing a stake of 7,724 shares — an estimated $4.19M sold.

Redwood Investments first reported a position in REGN in Q2 2013 and held it in 11 quarters. The position peaked at $7.82M in Q1 2014. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

  • Redwood Investments reported no remaining Regeneron Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Redwood Investments sold 7,724 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $4.19M.
  • Redwood Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Redwood Investments's Regeneron Pharmaceuticals position peaked at $7.82M in Q1 2014.
  • 550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Redwood Investments's 13F filing for Q1 2016, filed 20 Apr 2016.